The novel Raf inhibitor Raf265 decreases Bcl-2 levels and confers TRAIL-sensitivity to neuroendocrine tumour cells (Q39593170)
Jump to navigation
Jump to search
scientific article published on 21 March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The novel Raf inhibitor Raf265 decreases Bcl-2 levels and confers TRAIL-sensitivity to neuroendocrine tumour cells |
scientific article published on 21 March 2011 |
Statements
1 reference
The novel Raf inhibitor Raf265 decreases Bcl-2 levels and confers TRAIL-sensitivity to neuroendocrine tumour cells (English)
1 reference
Kathrin Zitzmann
1 reference
Enrico de Toni
1 reference
Janina von Rüden
1 reference
Stephan Brand
1 reference
Burkhard Göke
1 reference
Rüdiger P Laubender
1 reference
Christoph J Auernhammer
1 reference
21 March 2011
1 reference
1 reference
Identifiers
1 reference